Table 2.
Phase 1/2 clinical trials of MSC transplantation in autoimmune disease
Allo indicates allogeneic; auto, autologous; IVI, intravenous infusion; SLE, systemic lupus erythematosus.
Phase 1/2 clinical trials of MSC transplantation in autoimmune disease
Allo indicates allogeneic; auto, autologous; IVI, intravenous infusion; SLE, systemic lupus erythematosus.
